Dr. Riaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Village Dr
Edgewood, KY 41017Phone+1 859-301-4000Fax+1 859-301-4001
Education & Training
- University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2017
- King Edward Medical UniversityClass of 2005
- Jewish Hospital of CincinnatiResidency, Internal Medicine
Certifications & Licensure
- OH State Medical License 2011 - 2026
- KY State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas Start of enrollment: 2019 Sep 11
Roles: Contact
Publications & Presentations
PubMed
- 7 citationsDurvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial.Shuchi Gulati, McKenzie Crist, Muhammed Kashif Riaz, Vinita Takiar, Maria Lehn
Clinical Cancer Research. 2023-05-15 - 8 citationsPhase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck.Jennifer L Leddon, Shuchi Gulati, Sulsal Haque, Casey Allen, Sarah Palackdharry
Clinical Cancer Research. 2022-08-15 - 3 citationsA phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer.Andrew J Frankart, Nooshin Hashemi Sadraei, Brad Huth, Kevin P Redmond, William L Barrett
Laryngoscope Investigative Otolaryngology. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: